another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict.
the study used data of 1,082 ct scans of stroke patients across 70 hospitals in britain..

..
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
please enter a valid email address
sign up